Related Experiment Video
Updated: Feb 10, 2026

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
Published on: March 14, 2014
Protocols for Studies on TMPRSS2/ERG in Prostate Cancer
Hubert Pakula1, Douglas E Linn1, Daniel R Schmidt2
1Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Abstract:
TMPRSS2/ERG is the most common type of gene fusions found in human prostate cancer. There are two important features of TMPRSS2/ERG fusions. One is that these gene fusions lead to ectopic expression of ERG, an ETS family transcription factor, in prostate epithelial cells from the 5' control region of an androgen/estrogen dual-responsive gene, TMPRSS2; the other is that ~60% of these fusions are generated via intrachromosomal deletion of the interstitial region between TMPRSS2 and ERG. To recapitulate these important aspects of TMPRSS2/ERG fusions, we generated several TMPRSS2/ERG knockin mouse models based on the endogenous Tmprss2 locus. We found that TMPRSS2/ERG represents an early event in prostate tumorigenesis, by sensitizing prostate cells for cooperation with other oncogenic events, such as PTEN-deficiency. We also found that the interstitial region between TMPRSS2 and ERG harbors at least one prostate tumor suppressor, ETS2, whose loss contributes to prostate cancer progression. In this protocol, we describe how these knockin mouse models can be utilized to study roles of TMPRSS2/ERG fusions in prostate cancer development both in vivo and in vitro.
Insights
TMPRSS2/ERG gene fusions are common in prostate cancer, driving early tumor development. These fusions also reveal ETS2 as a prostate tumor suppressor, crucial for cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- TMPRSS2/ERG gene fusions are the most frequent genetic alterations in human prostate cancer.
- These fusions result in the aberrant expression of ERG (ETS family transcription factor) in prostate cells.
- Approximately 60% of these fusions arise from intrachromosomal deletions between TMPRSS2 and ERG.
Purpose of the Study:
- To create and utilize TMPRSS2/ERG knockin mouse models to study their role in prostate cancer.
- To investigate the early events in prostate tumorigenesis driven by TMPRSS2/ERG.
- To identify potential tumor suppressors within the TMPRSS2-ERG interstitial region.
Main Methods:
- Generation of TMPRSS2/ERG knockin mouse models.
- In vivo and in vitro studies to analyze prostate cancer development.
- Analysis of gene expression and tumor suppressor roles.
Main Results:
- TMPRSS2/ERG acts as an early oncogenic event, sensitizing prostate cells to cooperate with other oncogenic events like PTEN deficiency.
- The interstitial region between TMPRSS2 and ERG contains ETS2, a prostate tumor suppressor.
- Loss of ETS2 contributes to prostate cancer progression.
Conclusions:
- TMPRSS2/ERG knockin mouse models are valuable tools for studying prostate cancer.
- TMPRSS2/ERG is an early driver of prostate cancer, and ETS2 loss contributes to its progression.
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Case Studies
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

